VivaBioCell’s Post

VivaBioCell reposted this

View organization page for ImmunityBio, Inc., graphic

19,865 followers

The FDA's green light for our first-in-class IL-15 receptor marks a new era in treating non–muscle-invasive bladder cancer (NMIBC). In this interview with Urology Times Dr. Patrick Soon-Shiong sheds light on the pivotal approval. Learn More: https://lnkd.in/gXxhSPrf

Dr. Soon-Shiong discusses the FDA approval of N-803 in NMIBC

Dr. Soon-Shiong discusses the FDA approval of N-803 in NMIBC

urologytimes.com

Kelly Tindel, Ph.D.

Senior Director, Quality, CMC, Bioanalytical, Process Improvement

5mo

Congratulations on this achievement. This work will contribute to paving the way to curing all forms of cancer.

There appears to be many non-believers in Dr. Patrick Soon-Shiong . I am not sure why. PSS  is a brilliant scientist and a great American.

James Hartt

Solo Practitioner Attorney at James D. Hartt, Attorney At Law

5mo

Cancer patients will no doubt rejoice at the prospect of non-chemo immunotherapy to fight the disease, and to do so MORE effectively than chemo with no serious adverse side effects. A new day in cancer treatment is finally here. Thanks ImmunityBio!

Like
Reply
Michael Choo

Market President at Success & Promise Healthcare

5mo

Many Congratulations Richard. Tell Patrick I said hello!

Like
Reply

Congratulations on a great achievement

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics